Toggle Nav
mobile icon
My Cart
Close
  • Menu
  • Setting

PDE

PDE (phosphodiesterases) catalyze the hydrolysis of cGMP and/or cAMP. Stimulus such as light, neurotransmitter and hormone trigger PDE to regulate various biological response including vascular smooth muscle proliferation/contraction, hormone secretion and plate aggregation etc.

Items 41-50 of 55

Page
per page
  1. S- (+)-Rolipram
    A4349 S- (+)-Rolipram
    Summary: CAMP-specific PDE4 inhibitor
      insoluble in H2O; ≥13.9 mg/mL
  2. Anagrelide HCl
    A4352 Anagrelide HCl
    Summary: Thrombocytopenic agent
      insoluble in EtOH; insoluble in H2O; ≥4.9 mg/mL
  3. AN-2728
    A3178 AN-2728
    Summary: PDE4 inhibitor,anti-inflammatory compound
      insoluble in H2O; ≥12.55 mg/mL
  4. Nortadalafil
    A3665 Nortadalafil
    Summary: PDE5 inhibitor
      ≥32.7 mg/mL
  5. Olprinone Hydrochloride
    A3683 Olprinone Hydrochloride
    Summary: Phosphodiesterase 3 (PDE3) inhibitor, selective
      insoluble in EtOH; ≥13.2 mg/mL
  6. PF-04447943
    A3713 PF-04447943
    Summary: PDE9 inhibitor
      Soluble in DMSO
  7. Sildenafil
    A3817 Sildenafil
    Target: Phosphodiesterases (PDEs)
    Summary: PDE5 inhibitor, selective
      ≥22.65 mg/mL
  8. Zardaverine
    A3950 Zardaverine
    Summary: PDE III and IV inhibitor
      Soluble in DMSO
  9. Amino Tadalafil
    C3266 Amino Tadalafil
    Summary: analog of tadalafil, a potent inhibitor of phosphodiesterase 5
      ≥57.4 mg/mL
  10. MBCQ
    C3510 MBCQ
    Summary: cGMP-specific phosphodiesterase PDE V inhibitor
      Soluble in DMSO

Items 41-50 of 55

Page
per page